The results showed that in colorectal cancer, the high expression of NOLC1 was closely related to multiple immune checkpoints, such as LAG3, CTLA-4, and PDCD1LG2, leading to immune tolerance or escape of tumor cells. This evidence concerns the gene PDCD1LG2 and neoplasm.